China, U.S. FDA Drug Inspections Said Unaffected By Changes In SFDA
This article was originally published in PharmAsia News
Executive Summary
The mutual inspection arrangement between the FDAs of China and the U.S. remain unaffected by recent changes in China's regulatory processes for food and drugs.